SEARCH

SEARCH BY CITATION

References

  • ALKONDON, M. & ALBUQUERQUE, E.X. (1993). Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes. J. Pharmacol. Exp. Ther., 265, 14551473.
  • BARRANTES, G.E., ROGERS, A.T., LINDSTROM, J. & WONNACOTT, S. (1995). α-Bungarotoxin binding sites in rat hippocampal and cortical cultures: initial characterisation, colocalisation with α7 subunits and up-regulation by chronic nicotine treatment. Brain Res., 672, 228236.
  • BENCHERIF, M., FOWLER, K., LUKAS, R.J. & LIPPIELLO, P.M. (1995). Mechanisms of up-regulation of neuronal nicotinic acetylcholine receptors in clonal cell lines and primary cultures of fetal rat brain. J. Pharmacol. Exp. Ther., 275, 987994.
  • BENWELL, M.E.M., BALFOUR, D.J.K. & ANDERSON, J.M. (1988). Evidence that tobacco smoking increases the density of (−)-[3H]-nicotine binding sites in human brain. J. Neurochem., 50, 12431247.
  • BREESE, C.R., MARKS, M.J., LOGEL, J., ADAMS, C.E., SULLIVAN, B., COLLINS, A.C. & LEONARD, S. (1997). Effect of smoking history on [3H]-nicotine binding in human postmortem brain. J. Pharmacol. Exp. Ther., 282, 713.
  • CHENG, Y.-C. & PRUSOFF, W.H. (1973). Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction. Biochem. Pharm., 22, 30993108.
  • DAVIES, A.R.L., HARDICK, D.J., BLAGBROUGH, I.S., POTTER, B.V.L., WOLSTENHOLME, A.J. & WONNACOTT, S. (1999). Characterisation of the binding of [3H]methylycaconitine: a new radioligand for labelling α7-type neuronal nicotinic acetylcholine receptors. Neuropharmacol., 38, 679690.
  • DE FIEBRE, C.M., MEYER, E.M., HENRY, J.C., MURASKIN, S.I., KEM, W.R. & PAPKE, R.L. (1995). Characterisation of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal α7/125I-α-bungarotoxin receptor subtypes. Mol. Pharm., 47, 164171.
  • DE KONINCK, P. & COOPER, E. (1995). Differential regulation of neuronal nicotinic ACh receptor subunit genes in cultured neonatal rat sympathetic neurones: specific induction of α7 by membrane depolarisation through a calcium/calmodulin-dependent kinase pathway. J. Neurosci., 15, 79667978.
  • FLORES, C.M., ROGERS, S.W., PABREZA, L.A., WOLFE, B.B. & KELLAR, K.J. (1992). A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is upregulated by chronic nicotine treatment. Mol. Pharmacol., 41, 3137.
  • GHOSH, A. & GREENBERG, M.E. (1995). Calcium signalling in neurons: molecular mechanisms and cellular consequences. Science, 268, 239247.
  • GOPALAKRISHNAN, M., MOLINARI, E.J. & SULLIVAN, J.P. (1997). Regulation of human α4β2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways. Mol. Pharmacol., 52, 524534.
  • GREENBERG, M.E., THOMPSON, M.A. & SHENG, M. (1992). Calcium regulation of immediate early gene transcription. J. Physiol. (Paris), 86, 99108.
  • GROTTICK, A.J., TRUBE, G., CORRIGAL, W.A., HUWYLER, J., MALHERBE, P., WYLER, R. & HIGGINS, G.A. (2000). Evidence that nicotinic α7 receptors are not involved in the hyperlocomotor and rewarding effects of nicotine. J. Pharmacol. Exp. Ther., 294, 11121119.
  • HUNTER, B.E., DE FIEBRE, C.M., PAPKE, R.L., KEM, W.R. & MEYER, E.M. (1994). A novel nicotinic agonist facilitates induction of long term potentiation in the rat hippocampus. Neurosci. Letts., 168, 130134.
  • KE, L., EISENHOUR, C.M., BENCHERIF, M. & LUKAS, R.J. (1998). Effects of chronic nicotine treatment on expression of diverse nicotinic acetylcholine receptor subtypes. I. Dose- and time-dependent effects of nicotine treatment. J. Pharmacol. Exp. Ther., 286, 825840.
  • LUKAS, R.J., NORMAN, S.A. & LUCERO, L. (1993). Characterisation of nicotinic acetylcholine receptors expressed by cells of the SH-SY5Y human neuroblastoma clonal line. Mol. Cell. Neurosci., 4, 112.
  • MACALLAN, D.R.E., LUNT, G.G., WONNACOTT, S., SWANSON, K.L., RAPOPORT, H. & ALBUQUERQUE, E.X. (1988). Methyllycaconitine and (+)-anatoxin-a differentiate between nicotinic receptors in vertebrate and invertebrate nervous systems. FEBS Lett., 226, 357363.
  • MANSVELDER, N. & MCGEHEE, D. (2000). Long term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron, 27, 349357.
  • MARKS, M.J., PAULY, J.R., GROSS, S.D., DENERIS, E.S., HEINEMANN, S.F. & COLLINS, A.C. (1992). Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J. Neurosci., 12, 27652784.
  • MARKWELL, M.A.K., HAAS, S.M., BIEBER, L.L. & TOLBERT, N.E. (1978). A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem., 87, 206210.
  • MOLINARI, E.J., DELBONO, O., MESSI, M.L., RENGANATHAN, M., ARNERIC, S.P., SULLIVAN, J.P. & GOPALAKRISNAN, M. (1998). Up-regulation of human α7 nicotinic receptors by chronic treatment with activator and antagonist ligands. Eur. J. Pharmacol., 347, 131139.
  • ORR-URTREGER, A., GOLDNER, F.M., SAEKI, M., LORENZO, I., GOLDBERG, L., DE BIASI, M., DANI, J.A., PATRICK, J. & BEAUDET, A.L. (1997). Mice deficient in the α7 neuronal nicotinic acetylcholine receptor lack α-bungarotoxin binding sites and hippocampal fast nicotinic currents. J. Neurosci., 17, 91659171.
  • PAULY, J.R., MARKS, M.J., GROSS, S.D. & COLLINS, A.C. (1991). An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment. J. Pharmacol. Exp. Ther., 258, 11271136.
  • PENG, X., GERZANICH, V., ANAND, R., WANG, F. & LINDSTROM, J. (1997). Chronic nicotine up-regulates α3 and α7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y. Mol. Pharmacol., 51, 776784.
  • PENG, X., GERZANICH, V., ANAND, R., WHITING, P.J. & LINDSTROM, J. (1994a). Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol. Pharmacol., 46, 523530.
  • PENG, X., KATZ, M., GERZANICH, V., ANAND, R. & LINDSTROM, J. (1994b). Human α7 acetylcholine receptor: cloning of the α7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional α7 hopmomers expressed in Xenopus oocytes. Mol. Pharmacol., 45, 546554.
  • QUIK, M., CHOMERIS, J., KOMOURIAN, J., LUKAS, R.J. & PUCHACZ, E. (1996). Similarity between rat brain nicotinic α-bungarotoxin receptors and stably expressed α-bungarotoxin binding sites. J. Neurochem., 67, 145154.
  • QUIK, M., GEERSTEN, S. & TRIFARO, J.M. (1987). Marked up-regulation of the αbungarotoxin site in adrenal chromaffin cells by specific nicotinic antagonists. Mol. Pharmacol., 31, 385391.
  • RIDLEY, D.L. & WONNACOTT, S. (1998). Modulation of α7- and α3-containing nicotinic receptor expression in SH-SY5Y cells and primary hippocampal neurones. Soc. Neurosci., 24, 331.5.
  • ROGERS, A. & WONNACOTT, S. (1997). Differential upregulation of α7 and α3 subunit-containing nicotinic acetylcholine receptors in rat hippocampal and PC12 cell cultures. Biochem. Soc. Trans., 25, 544s.
  • ROLE, L.W. & BERG, D.K. (1996). Nicotinic receptors in the development and modulation of CNS synapses. Neuron, 16, 10771085.
  • ROWELL, R.P. & LI, M. (1997). Dose-response relationship for nicotine-induced up-regulation of rat brain nicotinic receptors. J. Neurochem., 68, 19821989.
  • SÉGUÉLA, P., WADICHE, J., DINELEY-MILLER, K., DANI, J.A. & PATRICK, J.W. (1993). Molecular cloning, functional properties and distribution of rat brain α7: a nicotinic cation channel highly permeable to calcium. J. Neurosci., 13, 596604.
  • SHARPLES, C.G.V., KAISER, S., SOLIAKOV, L., MARKS, M.J., COLLINS, A.C., WASHBURN, M., WRIGHT, E., SPENCER, J.A., GALLAGHER, T., WHITEAKER, P. & WONNACOTT, S. (2000). UB-165: A novel nicotinic agonist with subtype selectivity implicates the α4β2* subtype in the modulation of dopamine release from rat striatal synaptosomes. J. Neurosci., 20, 27832791.
  • TOKUMISTO, H., CHIJIWA, T., HAGIWARA, M., MIZUTANI, A., TERASAWA, M. & HIDAKA, H. (1990). KN-62, 1-[N, O-Bis(5-isoquinolinesulfonyl)-N-methyl L-tyrosyl]-4-phenylpiperazine, a specific inhibitor of calcium/calmodulin-dependent protein kinase II. J. Biol. Chem., 265, 43154320.
  • VAUGHAN, P.F.T., KAYE, D.F., REEVE, H.L., BALL, S.G. & PEERS, C. (1993). Nicotinic receptor-mediated release of noradrenaline in the human neuroblastoma SH-SY5Y. J. Neurochem., 60, 21592166.
  • WANG, F., GERZANICH, V., WELLS, G., ANAND, R., PENG, X., KEYSER, K. & LINDSTROM, J. (1996). Assembly of human neuronal nicotinic receptor α5 subunits with α3, β2 and β4 subunits. J. Biol. Chem., 271, 1765617685.
  • WANG, F., NELSON, M.E., KURYATOV, A., OLALE, F., COOPER, J., KEYSER, K. & LINDSTROM, J. (1998). Chronic nicotine treatment up-regulates human α3β2 but not α3β4 acetylcholine receptors stably transfected in human embryonic kidney cells. J. Biol. Chem., 273, 2872128732.
  • WHITEAKER, P., SHARPLES, C.G.V. & WONNACOTT, S. (1998). Agonist induced up-regulation of α4β2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition. Mol. Pharmacol., 53, 950962.
  • WONNACOTT, S. (1990). The paradox of nicotinic acetylcholine receptor upregulation by nicotine. Trends Pharmacol. Sci., 11, 216219.
  • ZHANG, X., GONG, Z.-H., HELLSTRÖM-LINDAHL, E. & NORDBERG, A. (1995). Regulation of α4β2 nicotinic acetylcholine receptors in M10 cells following treatment with nicotinic agonists. NeuroReport, 6, 313317.
  • ZOLI, M., LÉNA, C., PICCIOTTO, M.R. & CHANGEUX, J.-P. (1998). Identification of four classes of brain nicotinic receptors using β2 mutant mice. J. Neurosci., 18, 44614472.